Source: Journal of gastrointestinal cancer. Unidade: FM
Subjects: NEOPLASIAS COLORRETAIS, METÁSTASE NEOPLÁSICA, QUIMIOTERAPIA COMBINADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Gustavo Dos Santos et al. Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a rechallenge regimen for heavily pretreated metastatic colorectal cancer patients. Journal of gastrointestinal cancer, v. 49, n. 4, p. 470-475, 2018Tradução . . Disponível em: https://doi.org/10.1007/s12029-017-0001-3. Acesso em: 13 out. 2024.APA
Fernandes, G. D. S., Braghiroli, M. I., Artioli, M., Paterlini, A. C. C. R., Teixeira, M. C., Gumz, B. P., et al. (2018). Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a rechallenge regimen for heavily pretreated metastatic colorectal cancer patients. Journal of gastrointestinal cancer, 49( 4), 470-475. doi:10.1007/s12029-017-0001-3NLM
Fernandes GDS, Braghiroli MI, Artioli M, Paterlini ACCR, Teixeira MC, Gumz BP, Girardi D da M, Braghiroli OFM, Costa FP, Hoff PMG. Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a rechallenge regimen for heavily pretreated metastatic colorectal cancer patients [Internet]. Journal of gastrointestinal cancer. 2018 ; 49( 4): 470-475.[citado 2024 out. 13 ] Available from: https://doi.org/10.1007/s12029-017-0001-3Vancouver
Fernandes GDS, Braghiroli MI, Artioli M, Paterlini ACCR, Teixeira MC, Gumz BP, Girardi D da M, Braghiroli OFM, Costa FP, Hoff PMG. Combination of Irinotecan, Oxaliplatin and 5-Fluorouracil as a rechallenge regimen for heavily pretreated metastatic colorectal cancer patients [Internet]. Journal of gastrointestinal cancer. 2018 ; 49( 4): 470-475.[citado 2024 out. 13 ] Available from: https://doi.org/10.1007/s12029-017-0001-3